Influenza News and Research

Latest Influenza News and Research

Vuvuzela unhealthy in more ways than one: Study

According to health experts, Vuvuzelas - the horns used by football fans celebrating last year's World Cup - not only cause noise pollution but may also spread diseases. According to a new study published in PLoS One journal it is seen that a short burst on the instrument creates a spittle shower similar to a sneeze, travelling at a four million droplets a second. Authors write that in crowded venues one person blowing a Vuvuzela could infect many others with airborne illness like the flu or TB.

24 May 2011

New study shows that closing schools, other measures limited H1N1 spread in Mexico

The H1N1 virus was new, and most of the cases occurred among young people. Health professionals and scientists weren’t sure at the onset what the world would encounter with the virus.

24 May 2011

Aethlon to introduce new adaptive dialysis-like affinity platform technology at C21 partnering conference

Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announces that Chairman and CEO James A. Joyce will present the Aethlon ADAPT™ system in a presentation at the C21 BioVentures™ Life Sciences Partnering Conference.

23 May 2011

WHO member states adopt resolutions on financing, reform and flu pandemic at World Health Assembly

A committee of WHO member governments this week at the World Health Assembly in Geneva "adopted a resolution on the future financing of the organisation and a broad set of reforms, as well as a resolution on the WHO's management of [the H1N1] influenza pandemic showing no evidence of wrongdoing," Intellectual Property Watch reports.

21 May 2011

African Americans with SLE have higher antibody response to influenza vaccination: Study

New research shows that African Americans with systemic lupus erythematosus had a higher antibody response to influenza vaccination than European American patients.

21 May 2011

Medivir reports positive results from ASPIRE TMC435 phase 2b study for genotype 1 chronic hepatitis C

Medivir AB, the emerging research-based specialty pharmaceutical company focused on infectious diseases, today announced results from the ASPIRE phase 2b study that evaluates the addition of once daily TMC435 to pegylated interferon and ribavirin in patients with genotype 1 chronic hepatitis C whose prior treatment with pegylated-interferon (PegIFN) and ribavirin (RBV) was unsuccessful either because they relapsed, had a partial response or had a null response.

20 May 2011

CSL welcomes historic pandemic agreement

CSL Biotherapies welcomed news overnight of a decision by the World Health Assembly to adopt the Pandemic Influenza Preparedness Framework for the Sharing of Influenza Viruses and Access to Vaccines and Other Benefits. The Framework is the culmination of several years work by a dedicated working group of the World Health Organisation (WHO) and paves the way for greater global collaboration between public and private stakeholders in preparing the world for possible future influenza pandemics.

19 May 2011

Early childhood food allergies increase risk of severe allergy-related conditions and asthma later in life

Early results from the largest cross-sectional national allergy study ever conducted, to be released later this month, demonstrate that food allergies commonly occur in infants and toddlers, while environmental allergies, such as to dust, ragweed and mold, are more common in older children and adults.

From Quest Diagnostics 18 May 2011

Workplace smoking ban improves respiratory health and reduces emergency admissions

Workplace smoking bans are gaining ground globally, and one study has shown that they may have significant health effects. The study, conducted by researchers in Dublin, found that emergency room admissions due to respiratory illness dropped significantly in Ireland after the implementation of a workplace smoking ban, compared to admissions that took place before the ban went into effect.

18 May 2011

WHO Director-General outlines vision for reform in World Health Assembly opening address

WHO Director-General Margaret Chan on Monday laid out her vision for reforming the international health agency in the opening address of the World Health Assembly in Geneva, saying she sees "a WHO that gives a bigger voice to the many partners working on health, but encourages them to speak with a coherent voice that responds, first and foremost, to the needs and priorities as defined by recipient countries," Intellectual Property Watch reports.

18 May 2011

Gastroenterologists have limited knowledge of appropriate immunizations for IBD patients, study finds

Researchers from Boston University School of Medicine, along with clinicians from Boston Medical Center, have found gastroenterologist knowledge of the appropriate immunizations to recommend to the inflammatory bowel disease patient is limited.

17 May 2011

Concern over vaccine safety prevents parents from vaccinating asthmatic children

Concern over vaccine safety is one of the primary factors preventing parents from having their asthmatic children vaccinated for influenza, or flu, according to Michigan researchers. Parents who do not vaccinate their children are also less likely to view flu as a"trigger" for their child's asthma, the researchers noted.

17 May 2011

World Health Assembly begins in Geneva

As the 64th World Health Assembly gets underway in Geneva, the body will consider "an array of subjects pertaining to reforms of the organisation and its financing, vaccines, fake medicines, and influenza pandemic preparedness, as well as communicable and non-communicable diseases," Intellectual Property Watch reports.

17 May 2011

SYMBICORT long-term comparative study data in African American asthma patients presented at ATS 2011

AstraZeneca today announced results from a long-term study comparing SYMBICORT Inhalation Aerosol 160/4.5 mcg with budesonide pressurized metered-dose inhaler 160 mcg in self-reported African American patients with moderate to severe persistent asthma.

17 May 2011

Computationally designed antiviral proteins may fight against influenza

A research article May 12 in Science demonstrates the use of computational methods to design new antiviral proteins not found in nature, but capable of targeting specific surfaces of flu virus molecules.

16 May 2011

Sinovac first quarter sales increase 5.3% to $4.7 million

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today its unaudited first quarter financial results for the period ended March 31, 2011.

13 May 2011

Increase in public health spending linked with reduction of pandemic influenza mortality

Pandemic A (H1N1) 2009 mortality rates exhibited wide diversion between countries. Based on data from a total of 30 European countries, a study published in the journal PLoS ONE found that the greater the state financial "generosity" to health sector the lower the pandemic influenza mortality.

13 May 2011

Inovio first quarter total revenue increases to $3.1 million for 2011

Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended March 31, 2011.

11 May 2011

Aethlon seeks FDA meeting for re-initiation of Hemopurifier IDE study

Aethlon Medical, Inc. announces that it has submitted a request to the U.S. Food and Drug Administration for a face-to-face meeting to discuss re-initiation of an Investigational Device Exemption (IDE) study of the Aethlon Hemopurifier in the United States.

10 May 2011

Novavax first quarter net loss decreases to $7.5 million

Novavax, Inc. today announced its financial results for the first quarter ended March 31, 2011.

9 May 2011

Influenza News and Research

Latest Influenza News and Research

Vuvuzela unhealthy in more ways than one: Study

New study shows that closing schools, other measures limited H1N1 spread in Mexico

Aethlon to introduce new adaptive dialysis-like affinity platform technology at C21 partnering conference

WHO member states adopt resolutions on financing, reform and flu pandemic at World Health Assembly

African Americans with SLE have higher antibody response to influenza vaccination: Study

Medivir reports positive results from ASPIRE TMC435 phase 2b study for genotype 1 chronic hepatitis C

CSL welcomes historic pandemic agreement

Early childhood food allergies increase risk of severe allergy-related conditions and asthma later in life

Workplace smoking ban improves respiratory health and reduces emergency admissions

WHO Director-General outlines vision for reform in World Health Assembly opening address

Gastroenterologists have limited knowledge of appropriate immunizations for IBD patients, study finds

Concern over vaccine safety prevents parents from vaccinating asthmatic children

World Health Assembly begins in Geneva

SYMBICORT long-term comparative study data in African American asthma patients presented at ATS 2011

Computationally designed antiviral proteins may fight against influenza

Sinovac first quarter sales increase 5.3% to $4.7 million

Increase in public health spending linked with reduction of pandemic influenza mortality

Inovio first quarter total revenue increases to $3.1 million for 2011

Aethlon seeks FDA meeting for re-initiation of Hemopurifier IDE study

Novavax first quarter net loss decreases to $7.5 million

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Influenza News and Research

Latest Influenza News and Research

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Newsletters you may be interested in